NEW YORK (360Dx) – Confer Health announced today it has raised $9.5 million for the development of its home-based testing technology, which will be initially targeted at fertility testing.

Social Capital led the financing. Its Founder and CEO Chamath Palihapitiya has joined Confer's board, the Boston-based company said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Sponsored by
Advanced Cell Diagnostics

This webinar will demonstrate how a research team at the Firestone Institute for Respiratory Health at McMaster University developed a cellular and molecular phenotyping pipeline using archived samples of lung tissue derived from patients diagnosed with fibrotic interstitial lung disease.